ClinConnect ClinConnect Logo
Search / Trial NCT06518252

Risk of Sudden Cardiac Death in UN Athletes

Launched by UNIVERSIDAD NACIONAL DE COLOMBIA · Jul 18, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Sudden Death Of The Athlete Electrocardiogram University Sports.

ClinConnect Summary

This clinical trial is studying the risk of sudden cardiac death in athletes, particularly those involved in high-performance sports. The goal is to find ways to identify athletes who may be at an increased risk of experiencing serious heart problems during their activities. The researchers will use a special heart test called a 12-lead electrocardiogram (ECG) to examine the heart's electrical activity and look for any issues that could lead to dangerous situations. Additionally, participants will fill out questionnaires about their personal and family health histories to help identify any other risk factors.

To participate in this study, athletes must be between 18 and 35 years old, have been training for over two years, and practice their sport for at least six hours each week. They should not have a history of certain medical conditions, including specific heart diseases or the use of certain medications. Participants can expect to undergo heart evaluations and complete health questionnaires, which will help create personalized risk profiles. This research is important because it aims to develop better strategies for keeping athletes safe and healthy during their sports activities.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Athletes belonging to the sports teams of the National University of Colombia, Bogotá campus.
  • Subject's sports history (practice time exceeding 2 years).
  • Individuals aged 18 to 35 years, without discrimination based on biological sex.
  • Training time exceeding 6 hours per week in their sports modality (weekly training record).
  • Personal history of cardiovascular disease (cardiac malformations or previously detected sudden death risk).
  • Athletes who attend at least 90% of the training sessions planned by the coach.
  • Exclusion Criteria:
  • Personal history of metabolic (type 1 and 2 diabetes mellitus), neurological (spinal cord injury), or renal disease.
  • Routine consumption of alcohol or psychoactive substances.
  • Use of antihypertensive medications, beta-blockers, or inotropes.
  • Cardiovascular disease diagnosed with previously established pharmacological management.

About Universidad Nacional De Colombia

The Universidad Nacional de Colombia, a prestigious institution renowned for its commitment to academic excellence and research innovation, serves as a leading clinical trial sponsor in Colombia. With a focus on advancing medical knowledge and improving healthcare outcomes, the university conducts rigorous clinical trials across various fields, including pharmacology, public health, and epidemiology. By leveraging its multidisciplinary expertise and state-of-the-art facilities, the Universidad Nacional de Colombia aims to foster collaborative research initiatives that address pressing health challenges both locally and globally, while adhering to the highest ethical standards and regulatory requirements.

Locations

Bogotá, Cundinamarca, Colombia

Patients applied

0 patients applied

Trial Officials

Wilder Villamil-Parra, PhD.Sciences

Study Director

Universidad Nacional de Colombia

Erica Mancera-Soto, PhD.Sciences

Study Chair

Universidad Nacional de Colombia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported